Company · Healthcare
Madrid
Every investor coverage indicates participated in a round Hospital HM Sanchinarro raised.
Companies Hospital HM Sanchinarro acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Hospital HM Sanchinarro. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
OncoSil Medical says a Madrid hospital has treated its 100th Spanish pancreatic cancer patient with its brachytherapy device, as the ASX-listed company focuses on deepening use across its 11 treatment sites.